These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Role of Wnt/β-catenin and RANKL/OPG in bone healing of diabetic Charcot arthropathy patients. Folestad A; Ålund M; Asteberg S; Fowelin J; Aurell Y; Göthlin J; Cassuto J Acta Orthop; 2015; 86(4):415-25. PubMed ID: 25811776 [TBL] [Abstract][Full Text] [Related]
4. The Charcot foot in diabetes. Rogers LC; Frykberg RG; Armstrong DG; Boulton AJ; Edmonds M; Van GH; Hartemann A; Game F; Jeffcoate W; Jirkovska A; Jude E; Morbach S; Morrison WB; Pinzur M; Pitocco D; Sanders L; Wukich DK; Uccioli L J Am Podiatr Med Assoc; 2011; 101(5):437-46. PubMed ID: 21957276 [TBL] [Abstract][Full Text] [Related]
5. Vascular calcification and osteolysis in diabetic neuropathy-is RANK-L the missing link? Jeffcoate W Diabetologia; 2004 Sep; 47(9):1488-92. PubMed ID: 15322748 [TBL] [Abstract][Full Text] [Related]
6. Increased calcification in osteoprotegerin-deficient smooth muscle cells: Dependence on receptor activator of NF-κB ligand and interleukin 6. Callegari A; Coons ML; Ricks JL; Rosenfeld ME; Scatena M J Vasc Res; 2014; 51(2):118-31. PubMed ID: 24642764 [TBL] [Abstract][Full Text] [Related]
7. Confronting a dramatic situation: the charcot foot complicated by osteomyelitis. Dalla Paola L Int J Low Extrem Wounds; 2014 Dec; 13(4):247-62. PubMed ID: 25123373 [TBL] [Abstract][Full Text] [Related]
8. The RANKL/RANK/OPG signaling pathway mediates medial arterial calcification in diabetic Charcot neuroarthropathy. Ndip A; Williams A; Jude EB; Serracino-Inglott F; Richardson S; Smyth JV; Boulton AJ; Alexander MY Diabetes; 2011 Aug; 60(8):2187-96. PubMed ID: 21659498 [TBL] [Abstract][Full Text] [Related]
9. Management of the diabetic Charcot foot. Frykberg RG; Mendeszoon E Diabetes Metab Res Rev; 2000; 16 Suppl 1():S59-65. PubMed ID: 11054891 [TBL] [Abstract][Full Text] [Related]
10. The role of proinflammatory cytokines in the cause of neuropathic osteoarthropathy (acute Charcot foot) in diabetes. Jeffcoate WJ; Game F; Cavanagh PR Lancet; 2005 Dec; 366(9502):2058-61. PubMed ID: 16338454 [TBL] [Abstract][Full Text] [Related]
11. Below-knee arterial calcification in type 2 diabetes: association with receptor activator of nuclear factor κB ligand, osteoprotegerin, and neuropathy. Bourron O; Aubert CE; Liabeuf S; Cluzel P; Lajat-Kiss F; Dadon M; Komajda M; Mentaverri R; Brazier M; Pierucci A; Morel F; Jacqueminet S; Massy ZA; Hartemann A J Clin Endocrinol Metab; 2014 Nov; 99(11):4250-8. PubMed ID: 25013993 [TBL] [Abstract][Full Text] [Related]
12. The galectin-3/RAGE dyad modulates vascular osteogenesis in atherosclerosis. Menini S; Iacobini C; Ricci C; Blasetti Fantauzzi C; Salvi L; Pesce CM; Relucenti M; Familiari G; Taurino M; Pugliese G Cardiovasc Res; 2013 Dec; 100(3):472-80. PubMed ID: 23975852 [TBL] [Abstract][Full Text] [Related]
13. Calcaneal bone mineral density in patients with Charcot neuropathic osteoarthropathy: differences between Type 1 and Type 2 diabetes. Petrova NL; Foster AV; Edmonds ME Diabet Med; 2005 Jun; 22(6):756-61. PubMed ID: 15910628 [TBL] [Abstract][Full Text] [Related]
14. Prelamin A accelerates vascular calcification via activation of the DNA damage response and senescence-associated secretory phenotype in vascular smooth muscle cells. Liu Y; Drozdov I; Shroff R; Beltran LE; Shanahan CM Circ Res; 2013 May; 112(10):e99-109. PubMed ID: 23564641 [TBL] [Abstract][Full Text] [Related]
15. Oxidative stress contributes to vascular calcification in patients with chronic kidney disease. Huang M; Zheng L; Xu H; Tang D; Lin L; Zhang J; Li C; Wang W; Yuan Q; Tao L; Ye Z J Mol Cell Cardiol; 2020 Jan; 138():256-268. PubMed ID: 31866376 [TBL] [Abstract][Full Text] [Related]
16. Charcot Pathogenesis: A Study of In Vivo Gene Expression. Connors JC; Hardy MA; Kishman LL; Botek GG; Verdin CJ; Rao NM; Kingsley JD J Foot Ankle Surg; 2018; 57(6):1067-1072. PubMed ID: 30368423 [TBL] [Abstract][Full Text] [Related]